LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 98 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $72,000 | -89.7% | 15,700 | -86.8% | 0.00% | -100.0% |
| Q1 2021 | $697,000 | -0.4% | 118,800 | -42.0% | 0.00% | 0.0% |
| Q4 2020 | $700,000 | +55.2% | 204,900 | -34.6% | 0.00% | +50.0% |
| Q3 2020 | $451,000 | -3.0% | 313,300 | +34.3% | 0.00% | 0.0% |
| Q2 2020 | $465,000 | +46.7% | 233,200 | +43.2% | 0.00% | 0.0% |
| Q1 2020 | $317,000 | -40.6% | 162,800 | +26.3% | 0.00% | 0.0% |
| Q4 2019 | $534,000 | – | 128,900 | – | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $697,000 | -10.6% | 50,400 | +16.7% | 0.00% | 0.0% |
| Q3 2016 | $780,000 | -0.5% | 43,200 | -21.0% | 0.00% | 0.0% |
| Q2 2016 | $784,000 | +13.0% | 54,700 | -5.9% | 0.00% | 0.0% |
| Q1 2016 | $694,000 | +17250.0% | 58,100 | +16220.2% | 0.00% | – |
| Q4 2015 | $4,000 | +33.3% | 356 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | +50.0% | 356 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | – | 356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |